Over the last 7 days, the Pharma industry has risen 5.6%, driven by gains from Clarity Pharmaceuticals of 17%. In the same time, Neuren Pharmaceuticals was down 15%. This takes the industry's 12 month performance to a gain of 64%. As for the next few years, earnings are expected to grow by 32% per annum.
Has the Australian Pharma Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 03 Jun 2024 | AU$6.6b | AU$1.2b | -AU$344,938,684.00 | 13.8x | -19.1x | 5.5x |
Wed, 01 May 2024 | AU$5.6b | AU$1.2b | -AU$374,923,684.00 | 13.3x | -14.9x | 4.6x |
Fri, 29 Mar 2024 | AU$5.8b | AU$1.2b | -AU$374,923,684.00 | 15x | -15.6x | 4.8x |
Sun, 25 Feb 2024 | AU$5.4b | AU$896.8m | -AU$524,400,271.00 | 20.6x | -10.3x | 6x |
Tue, 23 Jan 2024 | AU$5.6b | AU$896.3m | -AU$589,604,392.00 | 21x | -9.6x | 6.3x |
Thu, 21 Dec 2023 | AU$5.4b | AU$896.3m | -AU$589,604,392.00 | 18.6x | -9.2x | 6.1x |
Sat, 18 Nov 2023 | AU$4.1b | AU$893.0m | -AU$595,020,018.00 | 17.9x | -6.8x | 4.6x |
Mon, 16 Oct 2023 | AU$3.5b | AU$900.3m | -AU$587,952,018.00 | 19.8x | -5.9x | 3.9x |
Wed, 13 Sep 2023 | AU$3.8b | AU$900.3m | -AU$587,952,018.00 | 19.3x | -6.5x | 4.3x |
Fri, 11 Aug 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 20.4x | -6.5x | 4x |
Sun, 09 Jul 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 24.5x | -6.5x | 4x |
Tue, 06 Jun 2023 | AU$4.0b | AU$999.0m | -AU$624,794,303.00 | 19.7x | -6.3x | 4x |
Thu, 04 May 2023 | AU$4.2b | AU$993.2m | -AU$641,969,868.00 | 21.2x | -6.6x | 4.2x |
Sat, 01 Apr 2023 | AU$4.2b | AU$995.9m | -AU$648,651,745.00 | 18.3x | -6.4x | 4.2x |
Mon, 27 Feb 2023 | AU$3.6b | AU$1.0b | -AU$596,427,649.00 | 17.9x | -6x | 3.4x |
Wed, 25 Jan 2023 | AU$3.9b | AU$951.8m | -AU$584,038,383.00 | 17.2x | -6.7x | 4.1x |
Fri, 23 Dec 2022 | AU$3.9b | AU$948.3m | -AU$544,428,006.00 | 13.2x | -7.1x | 4.1x |
Sun, 20 Nov 2022 | AU$4.4b | AU$948.3m | -AU$544,428,005.00 | 12.9x | -8x | 4.6x |
Tue, 18 Oct 2022 | AU$4.2b | AU$946.2m | -AU$548,400,005.00 | 12x | -7.7x | 4.5x |
Thu, 15 Sep 2022 | AU$4.3b | AU$943.4m | -AU$537,548,829.00 | 12.5x | -8x | 4.5x |
Sat, 13 Aug 2022 | AU$4.2b | AU$819.9m | -AU$337,428,683.00 | 15.1x | -12.4x | 5.1x |
Mon, 11 Jul 2022 | AU$3.5b | AU$818.2m | -AU$353,932,589.00 | 14.6x | -9.8x | 4.2x |
Wed, 08 Jun 2022 | AU$3.7b | AU$818.2m | -AU$353,932,589.00 | 14.8x | -10.5x | 4.6x |
Fri, 06 May 2022 | AU$4.0b | AU$800.9m | -AU$348,637,558.00 | 14.7x | -11.3x | 4.9x |
Sun, 03 Apr 2022 | AU$4.2b | AU$799.2m | -AU$341,805,125.00 | 18.2x | -12.3x | 5.3x |
Tue, 01 Mar 2022 | AU$4.2b | AU$795.8m | -AU$336,740,789.00 | 18.2x | -12.6x | 5.3x |
Thu, 27 Jan 2022 | AU$4.4b | AU$758.4m | -AU$450,516,414.00 | 19.1x | -9.7x | 5.8x |
Sat, 25 Dec 2021 | AU$4.9b | AU$758.4m | -AU$450,516,414.00 | 23.9x | -10.8x | 6.4x |
Mon, 22 Nov 2021 | AU$4.7b | AU$758.4m | -AU$447,307,205.00 | 23.2x | -10.6x | 6.2x |
Wed, 20 Oct 2021 | AU$4.8b | AU$753.7m | -AU$446,982,450.00 | 23.5x | -10.7x | 6.4x |
Fri, 17 Sep 2021 | AU$4.9b | AU$753.9m | -AU$445,060,581.00 | 21x | -11x | 6.5x |
Sun, 15 Aug 2021 | AU$4.2b | AU$752.8m | -AU$442,004,016.00 | 21.4x | -9.5x | 5.6x |
Thu, 10 Jun 2021 | AU$4.5b | AU$758.8m | -AU$452,149,714.00 | 12.7x | -9.9x | 5.9x |
-9.9x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | -0.33% | |
Healthcare | 0.41% | |
Pharma | 5.60% | |
Pharma | 5.60% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
CU6 Clarity Pharmaceuticals | AU$5.23 | 17.3% +AU$239.5m | 588.2% | PS171.5x | |
LTP LTR Pharma | AU$0.64 | 33.3% +AU$22.3m | n/a | n/a | |
PER Percheron Therapeutics | AU$0.089 | 23.6% +AU$15.3m | 48.3% | PS35.1x | |
PAA PharmAust | AU$0.21 | 16.2% +AU$11.9m | 179.2% | PS22.9x | |
IVX Invion | AU$0.005 | 25.0% +AU$6.4m | -16.7% | PS7.3x |